There’s the Rub: a novel ubiquitin-like modification linked to cell cycle regulation

  1. Mark Hochstrasser
  1. Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois 60637 USA

Covalent attachment of the polypeptide ubiquitin to intracellular proteins is achieved through an intricate and highly conserved enzymatic pathway that is beginning to be understood in some detail (for review, see Wilkinson 1995; Hochstrasser 1996; Pickart 1997). Ubiquitin is joined reversibly to proteins by an isopeptide linkage of the carboxy-terminal carboxyl group of ubiquitin to lysine side chains of the acceptor proteins (Fig. ). In the majority of cases examined, the modified protein, particularly when it is attached to multiple ubiquitin molecules, is targeted to a large, abundant intracellular protease called the proteasome, which degrades the substrate into small peptides but allows recycling of the ubiquitin moieties.

 The ubiquitin–protein conjugation pathway. The ligation mechanisms of Rub1/NEDD8 and other Ubls are likely to be very similar. In the first step of the ubiquitin pathway, the carboxy-terminal carboxyl group of ubiquitin (Ub) is activated by E1 (Uba1 in yeast) by formation of a mixed anhydride with AMP. The ubiquitin–adenylate is then transferred to a cysteine residue of E1, resulting in a ubiquitin–E1 thiolester. (A second, tightly bound ubiquitin-adenylate is formed after this step but is not shown here.) Thereafter, the ubiquitin is transferred to a reactive cysteine of a second enzyme, E2 (Ubc). Although E2 enzymes can sometimes directly catalyze isopeptide bond formation between ubiquitin and substrate protein in vitro, this reaction generally requires the aid of at least one additional factor, called E3 or ubiquitin–protein ligase. Currently, there is evidence for two different E3-based mechanisms for substrate ubiquitination. For at least one structural subclass of E3s (Scheffner et al. 1995), ubiquitin is transferred from the E2 to a thiol group on the E3 protein and only then is conjugated to a lysine side chain of the substrate (pathway I). For other E3s, the E3 appears to function more as an adaptor, juxtaposing the E2-ubiquitin thiolester and substrate to allow transfer of ubiquitin directly from the E2 (pathway II). For the Rub1/NEDD8 and Smt3/SUMO-1 pathways, both E1-like and E2-like enzymes have been identified, but no E3-like activities are known yet.


Over the past few years, it has emerged that eukaryotes also express a set of ubiquitin-like proteins (Ubls) that are significantly diverged from ubiquitin itself yet are also ligated to other proteins (Haas and Siepmann 1997; Johnson and Hochstrasser 1997). The reactions involving these variants appear to have much in common with those of ubiquitin, but the Ubls have novel regulatory functions not necessarily linked to proteolysis. In this issue, Lammer et al. describe an unexpected connection between a Ubl called Rub1 (related toubiquitin 1) from the yeastSaccharomyces cerevisiae and a ubiquitin–protein ligase complex that is critical for progression from G1 to S phase in the cell cycle. In this commentary, I will discuss these new results together with recent related developments on the mechanisms and functions of Ubl–protein ligation.

Rub1 and NEDD8: new Ubl modifiers

A distinctive feature of ubiquitin is that it is always synthesized in precursor form, with one or more amino acids following a Gly–Gly dipeptide that forms the carboxyl terminus of the mature protein (Fig. A). These “tail” sequences are clipped off by members of a diverse group of enzymes called deubiquitinating enzymes. Analogous attributes turn out to be a hallmark of the subset of Ubls that also form covalent adducts with other proteins (Fig. A). In contrast, many Ubls have nonremovable ubiquitin-like domains, and these domains are invariably missing the Gly–Gly element.

 Conjugation-competent Ubls and their specific activating enzymes. (A) Sequence alignment of yeast ubiquitin (mature form) and the precursors of yeast Rub1 (PIR accession no.S51867), human NEDD8 (D23662), and yeast Smt3 (U27233) using the CLUSTALW algorithm. The arrow indicates the site of precursor cleavage. (B) Ubiquitin- and Ubl-activating enzymes. Smt3 is activated by a heterodimer of Aos1 and Uba2, with Uba2 carrying the catalytic Cys residue (in domain III) (Johnson et al. 1997). Rub1 activation in yeast requires both Enr2/Ula1 and Uba3. A heterodimer of the Enr2 and Uba3 orthologs from human has been observed; the complex is capable of activating NEDD8, the mammalian ortholog of Rub1 (see text). Sequence similarity boxes are those noted by Johnson et al. (1997).


Several years ago, the yeast genome project identified a novel DNA sequence with the potential for encoding a 77-residue protein that is 53% identical (72% similar) to ubiquitin (Hochstrasser 1996). Interestingly, the product of this gene, dubbed RUB1, is even more closely related (59% identity) to a protein encoded by a developmentally regulated gene from mammals called NEDD8(Kumar et al. 1993) (Fig. A). The predicted translation products of these genes include a Gly–Gly dipeptide followed by one or five additional residues, suggesting that these polypeptides might be conjugated to other proteins. Late last year it was reported that NEDD8 is carboxy-terminally processed and becomes covalently coupled to at least one cellular protein (Kamitani et al. 1997). The same has now been shown to be true for Rub1 in yeast (Lammer et al. 1998;Liakopoulos et al. 1998). A small number of Rub1–protein conjugates is readily detectable by immunoblot analysis, one of the most prominent involving, surprisingly, Cdc53, a protein that functions in ubiquitin–protein ligation. As will become clear below, Rub1 and NEDD8 are almost certainly functional homologs, and Rub1/NEDD8 ligation to proteins is likely to have important growth regulatory roles in plants, mammals, and presumably many other organisms.

The sequence differences between Rub1 and ubiquitin are clustered when viewed on the three-dimensional structure of ubiquitin, leaving the hydrophobic face of ubiquitin largely intact. Lysine residues at positions 29 and 48 are also conserved. These two lysines have both been shown to participate in polyubiquitin chain formation in yeast cells, and Lys-48 and the hydrophobic surface patch of ubiquitin have been implicated in substrate targeting to the proteasome (Pickart 1997). Based on these considerations, it is possible that modification by Rub1 can regulate the ubiquitination and/or degradation of at least some cellular proteins. Such conjugation might negatively regulate protein degradation by the proteasome if Rub1 attachment competed with ubiquitin conjugation but was less effective in proteasome targeting. Conversely, Rub1 might act as an enhancer of proteolysis if protein modification by Rub1 [poly(Rub1)?] were an efficient proteasome-targeting mechanism.

Ubl–protein ligation: a new twist on an old theme

All post-translational ubiquitination events begin with the activation of the carboxyl terminus of ubiquitin by the E1 enzyme (Fig.; see legend for details). Yeast cells have a single E1-encoding gene,UBA1, which is essential for viability. For several reasons, E1 is not likely to play a significant role in the selection of ubiquitination targets. Instead, the major determinant of substrate specificity in the ubiquitin conjugation pathway is the E2/E3 ubiquitin–protein ligase complex, which binds the substrate protein and catalyzes isopeptide bond formation with ubiquitin (Figs. and ). In yeast, 13 genes encoding E2-related enzymes have been identified in the complete genome sequence (Hochstrasser 1996), and both genetic and biochemical data indicate that different E2s participate in the ubiquitination of distinct substrates. Similarly, a number of structurally diverse E3 factors have been identified, and they are also involved in the degradation of distinct proteins. Significantly, there are now examples both of disparate E2s functioning either together or separately in the modification of individual substrates (Chen et al. 1993) and of the same E2 associating with distinct E3s, which then ubiquitinate different proteins (Skowyra et al. 1997). These observations have led to the idea that the ubiquitin conjugation system can expand its repertoire of substrate specificities through association of a limited set of E2 and E3 proteins into multiple heteromeric complexes (Chen et al. 1993; Skowyra et al. 1997).

 Sic1, a yeast CDK inhibitor, is ubiquitinated by the Cdc34–SCFCdc4 complex. SCFCdc4(Skp1–Cdc53–F-box protein Cdc4) is an E3 that contains three different polypeptides. The binding of Sic1 to the F-box protein Cdc4 requires Sic1 phosphorylation by the Cln–Cdc28 kinase. Covalent modification of Cdc53 by Rub1 is shown, but whether this form of Cdc53 is involved in Sic1 degradation is not known. At least in vitro, the modification is unlikely to be absolutely required because the carboxy-terminally truncated Cdc53 protein that is not Rub1-modified in vivo is still able to support Sic1 ubiquitination in yeast lysates (Feldman et al. 1997) (see text for details).


With the identification of conjugation-competent proteins that are related to but substantially diverged from ubiquitin, renewed interest has been directed toward the E1 and E1-like enzymes as they may be the primary factors responsible for distinguishing among ubiquitin and its molecular brethren. Consistent with this possibility, many residues not conserved between the Ubls and ubiquitin were shown by mutagenesis studies of ubiquitin to be important for E1 interaction (Burch and Haas 1994). An important advance in this area came from experiments byJohnson et al. (1997) on the activation of the yeast Ubl called Smt3, which is the ortholog of the vertebrate SUMO-1 protein and is involved in passage of yeast cells through the G2/M phase of the cell cycle (see Johnson and Hochstrasser 1997). They purified and characterized an enzyme capable of forming a thiolester with Smt3 in the presence of ATP, and, unexpectedly, the protein was found to be a heterodimer of Aos1 and Uba2 (Fig. B). Remarkably, Uba2 bears clear similarity to the carboxyl terminus of Uba1, the yeast E1, whereas Aos1 is related to the amino-terminal region of Uba1. The Smt3 thiolester is formed with the Uba2 subunit, but both subunits are required for Smt3 activation in vitro and in vivo. Thus, the yeast Smt3-activating enzyme resembles a split version of Uba1.

It turns out that Rub1/NEDD8 activation is performed by an exactly analogous heterodimeric E1-like complex. Using the ability of a fraction from a human HeLa cell lysate to form an ATP-dependent and DTT-sensitive adduct with radiolabeled NEDD8, Chau and coworkers purified a 110-kD complex that contained 49- and 60-kD subunits (T. Gladysheva, J. Pohl, F. Melandri, and V. Chau, unpubl.). The 49-kD subunit forms the apparent thiolester with NEDD8, and using microsequence data obtained from this polypeptide, these workers identified a gene that was predicted to encode a protein with sequence similarity to the carboxy-terminal region of E1s. The strongest similarity to any yeast gene was to a sequence encoding a putative E1-like protein, Uba3 (Hochstrasser 1996), that had been identified as part of the genome sequencing project. Peptides derived from the 60-kD subunit of the HeLa enzyme were identical to a previously identified protein called APP–BP1, which is highly similar to the amino-terminal domain of E1 (Chow et al. 1996). APP–BP1 (see below) was identified originally by its ability to bind to a cytoplasmic segment of the amyloid precursor protein (APP), which is the source of the amyloidogenic peptides that accumulate in patients with Alzheimer’s disease.

Independent of the above study, the Jentsch group identified two yeast proteins that together were capable of activating Rub1 (Liakopoulos et al. 1998). Based on the analysis of Smt3 activation, they reasoned that a different pair of UBA1-related genes of previously unknown function, UBA3 and ULA1/ENR2, might encode the components of a Rub1-activating complex. Uba3 was shown to form a thiolester with Rub1 in vitro but only in the presence of the Enr2 protein. Moreover, deletion of either UBA3 orENR2 from yeast cells eliminated all detectable Rub1–protein conjugates (at least five distinct species were seen by immunoblot analysis). Lammer et al. (1998) have also demonstrated that one of the subunits, Enr2, is required for Rub1–protein ligation in vivo. TheENR2 gene product is similar to the product of AXR1,an Arabidopsis thaliana gene that is required in the plant for developmental responses to the hormone auxin. AXR1 served as the starting point for the Estelle group’s investigation of the yeast E1-related proteins (Leyser et al. 1993).

An E1-like enzyme is not the only conjugation pathway component specific to a particular Ubl or ubiquitin. Smt3 and SUMO-1 both can form a thiolester with a specific E2-like protein, Ubc9, which does not work with ubiquitin (Desterro et al. 1997; Johnson and Blobel 1997;Schwarz et al. 1998). The same appears to be true for Rub1. Liakopoulos et al. (1998) find that Ubc12 is necessary for Rub1–protein conjugation in vivo, and in the presence of Enr2–Uba3, Ubc12 can form a thioester with Rub1 in vitro. One might also expect that there are Ubl-specific E3-like factors, but this remains to be determined.

Lest there remain any doubt about the conservation of the Rub1 and NEDD8 conjugation systems, Estelle and colleagues have found thatArabidopsis AXR1 (which is 40% identical to human APP–BP1), when combined in vitro with another protein they call ECR1, results in ECR1 thiolesters with either Rub1 or NEDD8 (M. Estelle, pers. comm.). Similarly, D. Liakopoulos and S. Jentsch (unpubl.) have expressed NEDD8 in yeast and found nearly the same conjugate pattern as with Rub1, including Cdc53; this conjugate profile also depended on Enr2, Uba3, and Ubc12.

In summary, conjugation of proteins to both Smt3/SUMO-1 and Rub1/NEDD8 depends on specific E2-like enzymes and a specific heterodimeric activating enzyme complex. This heterodimer organization of the E1-like factors is remarkably well conserved among yeast, plants, and mammals, suggesting that it provides some functional advantage. Conceivably, Ubl–protein ligation will involve combinatorial specificity of a sort analogous to that discussed earlier for E2s and E3s in ubiquitin–protein ligation, with the new wrinkle that different heterodimeric combinations of E1-related polypeptides (and possibly E2s) may contribute to selection of the appropriate modifier protein.

Rub1 and the regulation of cell cycle progression

Regulated ubiquitin-mediated protein turnover is one of the primary mechanisms governing passage through the cell cycle (Deshaies 1997). The central cell cycle regulator is the cyclin-dependent protein kinase (CDK; other organisms express multiple CDK variants), which is Cdc28 in budding yeast. From a regulatory perspective, the cell cycle can be regarded as a sequence of timed regulatory subunit eliminations and replacements in the Cdc28 kinase complex; these regulatory subunits are the cyclins, which are positive regulatory subunits, and the CDK inhibitors (CKIs). In all cases examined, proteolysis by the ubiquitin–proteasome pathway is the mechanism of subunit elimination. Additional proteins that must also be destroyed at specific times for cell cycle progression, for instance, Pds1 in yeast, are also degraded by this pathway by mechanisms regulated, directly or indirectly, by CDKs (Deshaies 1997) .

In S. cerevisiae, the G1–S transition is controlled by the destruction of a specific CKI, the Sic1 protein (Schwob et al. 1994). Two B-type cyclins, Clb5 and Clb6, appear in G1 and associate with Cdc28; these Cdc28 complexes are important for entry into S phase but are inactive through earlier parts of G1because they are bound tightly to Sic1, which accumulates shortly after mitosis. Sic1 then is phosphorylated by the G1 cyclin–Cdc28 kinase (Verma et al. 1997). Phosphorylation of Sic1 triggers its destruction by a specific E2/E3 ubiquitination complex (Fig. ) (Feldman et al. 1997; Skowyra et al. 1997). The E2 in this case is Cdc34, whereas the E3 is a complex of three polypeptides, Skp1, Cdc53, and Cdc4, which is called SCFCdc4. Substrate binding to SCFCdc4 appears to be mediated by a series of WD-40 repeats in Cdc4, whereas a sequence motif in Cdc4 called the F-box is necessary for binding to Skp1 (Bai et al. 1996). Skp1 helps tether Cdc4 to Cdc53, the latter providing the link between the substrate binding subunits of the E3 complex and Cdc34 (Willems et al. 1996). Interestingly, Cdc53 and Skp1 are part of several distinct E3 complexes. What is common among the variable subunits in these complexes is the presence of the F-box motif and multiple copies of either WD-40 or leucine-rich repeats (LRRs), which are both common protein–protein interaction elements. For instance, a complex formed by Skp1, Cdc53, and Grr1, the latter an F-box and LRR-containing protein, appears to target the Cln1 and Cln2 G1 cyclins for degradation (Skowyra et al. 1997).

In addition to ubiquitinating Sic1, the Cdc34/SCFCdc4 complex is also responsible for modification of Far1, a CKI required specifically to arrest the cell cycle in G1 in response to mating pheromones (Henchoz et al. 1997), and Cdc6, a protein essential for formation of prereplicative complexes (pre-RCs) at origins of DNA replication (Drury et al. 1997). Regulation of pre-RC assembly is important for making initiation of DNA replication dependent on passage through mitosis and in limiting replication to once per cell cycle. Cdc6 is normally present at high levels only during the G1 phase of the cell cycle. This is attributable to cell cycle-regulated transcription of the CDC6gene and to Cdc34/SCFCdc4-dependent degradation of the Cdc6 protein. Degradation of orthologs of Cdc6 in other species is likely to depend on ubiquitination by the equivalent of Cdc34/SCFCdc4 (Kominami and Toda 1997) .

This brings us back, finally, to the data of Lammer et al. (1998) on Rub1 modification of Cdc53. First, it must be admitted that therub1Δ mutant, as well asenr2Δ, uba3Δ, andubc12Δ strains, is distressingly healthy to anyone who would like to believe the Rub1 pathway is playing a key regulatory role in the cell cycle. It is interesting, however, is that when mutations in CDC34, CDC4, CDC53, or SKP1 are combined with the rub1Δ orenr2Δ mutations, the growth and cell cycle defects associated with the former group of mutations are enhanced significantly. These genetic interactions appear to be specific because combining the enr2Δ mutation with mutations in other components of the ubiquitin system or cell cycle machinery (including grr1Δ) does not cause comparable growth defects. Overproduction of Cdc34 or Cdc53 (but not, for reasons unknown, Cdc4) also sensitizes cells to loss of the Rub1 modification pathway. That these defects result from the absence of Rub1 conjugation to Cdc53 is suggested by the identification of a functional Cdc53 carboxy-terminal truncation that renders the protein resistant to Rub1 modification and at the same time makes cells sensitive to mutation ofCDC34. Moreover, overexpression of Cdc4 or Cdc34 inhibits the growth of cells bearing this truncated cdc53 allele but not cells carrying wild-type CDC53. A significant fraction of Cdc53 is modified by Rub1 in logarithmically growing wild-type yeast cultures, and this fraction increases substantially with overproduction of Cdc4 or Cdc34. Finally, it is interesting to note that mutations inSKP1 also prevent Rub1 linkage to Cdc53. This could be attributable either to structural alteration of Cdc53/Skp1-containing target complexes or to Skp1 involvement in a Rub1–protein conjugation pathway.

What exactly are the consequences of Rub1 modification? Attachment of Rub1 to Cdc53 might affect the partitioning of Cdc53 among different Cdc53-containing E3 complexes, and/or it may change the activity of the Cdc34/SCF complex toward specific substrates. Lammer et al. (1998) suggest that Cdc53 metabolic stability is not affected because both modified and unmodified forms of the protein are degraded fairly slowly. In their pulse-chase experiments, it does appear that the Rub1–Cdc53 conjugate might persist slightly longer than the free form (Cdc53 turnover was not tested in arub1 mutant). It will be important to determine whether NEDD8 and other Rub1 orthologs also modify cullins from other organisms (cullins comprise a well-conserved family of proteins related to Cdc53).

Many of the components of Cdc34/SCF complexes appear to be widely conserved, and reports of new links between SCFs and the regulation of cell proliferation and development are now appearing in many quarters. In Caenorhabditis elegans, the cullincul-1 is required for developmentally programmed transitions from G1 to G0 or to apoptotic pathways, so null mutants display a general hyperplasia; these mutants also appear to be abnormal in G-to-S phase regulation (Kipreos et al. 1996). Estelle and colleagues described a plant F box-containing protein, TIR1, that is also critical for response to auxin and functions in the same response pathway as AXR1 Ruegger et al. 1998). Drosophila limb patterning requires a protein called Slimb, an F-box protein related to Cdc4 that is important for processing or degradation of transcription factors regulated by the Wingless and Hedgehog signaling pathways (Jiang and Struhl 1998). In the fission yeast S. pombe, a protein called pop1 is critical for ubiquitination and degradation of cdc18; pop1 is closed related to Cdc4 of S. cerevisiae, and cdc18 is the likely ortholog of Cdc6 (Kominami and Toda 1997). Finally, mammalian cells contain a ubiquitination complex very similar to Cdc34/SCF (Lisztwan et al. 1998). This complex includes Cdc34, Skp1, CUL-1, and Skp2, with the latter two being the apparent counterparts of yeast Cdc53 and Grr1, respectively. Whether the cullins in any of these complexes are subject to Rub1/NEDD8 modification remains to be tested, but it is notable that a very prominent NEDD8–protein conjugate of 90–97 kD was observed in human cell extracts by Kamitani et al. (1997), which would be compatible with a CUL-1 conjugate.

There are many obvious mechanistic and functional questions about Rub1/NEDD8 modification of proteins, but perhaps the most pressing concerns the apparent role of Rub1–Cdc53 conjugation in cell cycle regulation. To get at this issue, it is necessary first to consider the very different consequences of mutations in regulators of the G1/S transition in S. cerevisiaeversus other organisms. The reason this is likely to be relevant is the recent discovery (see Lammer et al. 1998) that the ts41 hamster cell line (Handeli and Weintraub 1992) harbors a temperature-sensitive allele of SMC1, a gene that is nearly identical to humanAPPBP1, which encodes a subunit of the NEDD8-activating enzyme (see above). When ts41 cells are shifted to nonpermissive temperature, they traverse multiple S phases without intervening mitoses. This block to cell proliferation is in sharp contrast to the lack of obvious growth defect in yeastenr2Δ cells. Instead, the ts41 defect is much more reminiscent of S. pombe mutants with defects in G1/S regulators, which also uncouple the coordination of DNA replication and mitosis. Mutation of pop1, the Cdc4-like protein (see above), results in both accumulation of cdc18, and rereplication of the genome (Kominami and Toda 1997). Polyploidization is also observed in wild-type strains overproducing cdc18 (Brown et al. 1997). In contrast, constitutive overexpression of either wild-type or stable Cdc6 in budding yeast does not induce rereplication, suggesting the existence of a redundant mechanism for prevention of more than one S phase in this organism (Drury et al. 1997). Interestingly, both Cdc6 and cdc18 bind tightly to CDK–cyclin B complexes, and Cdc6 inhibits kinase activity (Elsasser et al. 1996;Brown et al. 1997).

It is possible that the apparent redundancies in Cdc34–SCFCdc4 regulation and in prevention of rereplication in budding yeast are not coincidental. For instance, the Rub1 modification of Cdc53 may be particularly important for SCFCdc4 to ubiquitinate Cdc6 rather than Sic1, but because Cdc6 degradation is not essential for cell cycle progression in S. cerevisiae, deletion of the Rub1 pathway is without major effect. In cells without Rub1 and defective for Cdc34/SCFCdc4, the combined accumulation of Cdc6 and Sic1 may reduce Clb–Cdc28 activity below that required to drive cells into S phase (Far1 accumulation, by inhibiting Cln–Cdc28, may contribute indirectly as well). It is also conceivable that Rub1–Cdc53 conjugation specifically enhances Cln ubiquitination by Cdc34/SCF. Cln degradation also is not essential for cell cycle progression (Lanker et al. 1996), but failure to eliminate the Clns may sufficiently inhibit reloading of Cdc28 with Clb subunits to block the G1-to-S phase transition in cells also compromised for Cdc34/SCFCdc4. Perhaps a simpler idea is that Rub1 modification of Cdc53 enhances Cdc34/SCFCdc4 activity toward all substrates. When loss of the Rub1 pathway is combined with mutations or manipulations that further compromise Cdc34/SCFCdc4 assembly or activity, the activity of the complex may drop below some threshold required for viability. Another possibility is that Rub1 conjugation to Cdc53 functions in a checkpoint pathway that ensures the proper temporal coupling of mitosis and DNA replication. In otherwise wild-type yeast cells grown under most conditions, no obvious growth defect would be expected from loss of the Rub1-dependent checkpoint.

Future directions

Clearly, these new data on Rub1 and NEDD8 conjugation raise more questions than they answer. The dichotomy between the consequences of defects in this pathway in budding yeast versus plants and mammals is especially vexing. Whether there are fundamental parallels between Rub1/NEDD8 and Smt3/SUMO-1 conjugation in cell cycle control is another question worth considering. An additional interesting analogy, discussed by Lammer et al. (1998), involves the human cullin CUL-2, which forms a complex with the von Hippel–Lindau tumor suppressor product, elongin B, and elongin C (Pause et al. 1997). Elongin C has similarity to Skp1, whereas elongin B is a Ubl. Perhaps Rub1 and elongin B have similar functions in their respective heteromeric complexes. It will be useful to identify additional substrates for Rub1/NEDD8, which may, among other things, illuminate the apparent participation of this pathway in transduction of signals from the cell surface, which is suggested by APP–BP1/SMC1 binding to plasma membrane APP in humans, and by the importance of AXR1 to the auxin reponse in plants. At the current pace of research in the cell cycle and ubiquitin fields, we should not have long to wait for insights into these issues.

Acknowledgments

I thank Vincent Chau, Mark Estelle, and Stefan Jentsch for sharing data prior to publication, and Ray Deshaies, Jeff Laney, and Cecile Pickart for many helpful comments on the manuscript. Work in my laboratory on the ubiquitin system is supported by National Institutes of Health grants GM46904 and GM53756.

Footnotes

  • E-MAIL ; FAX (773) 702-0439.

References

« Previous | Next Article »Table of Contents